Cellulose
CAS 9004-34-6
Cellulose (CAS 9004-34-6) is a pharmaceutical compound with 0 bioactivity targets and 1 adverse event association.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Cellulose is linked to DTXSID3050492 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| cellulose | 2221 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Cellulose used for in pharmaceutical contexts?
Cellulose (CAS 9004-34-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Cellulose?
Cellulose has 1 DrugCentral/FAERS adverse event association. Rendered reaction terms include Flatulence. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Cellulose also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Microcrystalline Cellulose with EU status "permitted".
What clinical phase is Cellulose in?
No phase 1-4 clinical development badge is rendered for Cellulose because the matched compound identifier rows do not contain a max-phase value.